Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CPSI
|
Claire Stephens
SVP, Post Acute Care |
BUY
Grant, award, or other acquisition
|
Direct | 5,559 Added 40.97% |
-
|
Mar 07
2022 |
FTHY
|
James A Bowen
Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 50.0% |
$354,800
$17.74 p/Share
|
Mar 07
2022 |
NRDS
|
Tim Chao Ming Chen
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 61,106 Added 50.0% |
$598,839
$9.8 p/Share
|
Mar 07
2022 |
HNGR
|
Vinit K Asar
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 69,110 Added 7.21% |
-
|
Mar 07
2022 |
HNGR
|
Peter A Stoy
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,943 Added 30.76% |
-
|
Mar 07
2022 |
HNGR
|
Scott Ranson
EVP, Chief Info Officer * |
BUY
Grant, award, or other acquisition
|
Direct | 7,199 Added 5.88% |
-
|
Mar 07
2022 |
HNGR
|
Keri Jolly
SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,414 Added 13.31% |
-
|
Mar 07
2022 |
HNGR
|
Gabrielle B. Adams
Vice President Accounting |
BUY
Grant, award, or other acquisition
|
Direct | 5,760 Added 7.69% |
-
|
Mar 07
2022 |
HNGR
|
Regina A Weger
President, SPS |
BUY
Grant, award, or other acquisition
|
Direct | 5,236 Added 15.35% |
-
|
Mar 07
2022 |
HNGR
|
Mitchell D Dobson
SVP, Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,451 Added 9.89% |
-
|
Mar 07
2022 |
HNGR
|
Thomas E Kiraly
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 21,597 Added 7.22% |
-
|
Mar 07
2022 |
HNGR
|
Thomas E Hartman
SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 10,733 Added 6.99% |
-
|
Mar 07
2022 |
HNGR
|
James H Campbell
SVP, Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,283 Added 10.57% |
-
|
Mar 07
2022 |
SWBI
|
Deana L Mc Pherson |
SELL
Payment of exercise price or tax liability
|
Direct | 2,033 Reduced 3.3% |
$31,837
$15.66 p/Share
|
Mar 07
2022 |
PLOW
|
Sarah C Lauber
EVP & CFO |
SELL
Open market or private sale
|
Direct | 3,888 Reduced 12.52% |
$141,756
$36.46 p/Share
|
Mar 07
2022 |
PLOW
|
Jon J Sisulak
Controller |
SELL
Open market or private sale
|
Direct | 350 Reduced 6.14% |
$12,761
$36.46 p/Share
|
Mar 07
2022 |
PLOW
|
Linda R Evans
CHRO |
SELL
Open market or private sale
|
Direct | 1,122 Reduced 4.19% |
$40,908
$36.46 p/Share
|
Mar 07
2022 |
PLOW
|
Keith Hagelin
Pres. Work Truck Attachments |
SELL
Open market or private sale
|
Direct | 2,540 Reduced 2.89% |
$92,608
$36.46 p/Share
|
Mar 07
2022 |
PLOW
|
Robert L Mc Cormick
President and CEO |
SELL
Open market or private sale
|
Direct | 10,260 Reduced 21.19% |
$374,080
$36.46 p/Share
|
Mar 07
2022 |
CRLKP
|
Robert A Miles
President, Bags |
SELL
Payment of exercise price or tax liability
|
Direct | 5,223 Reduced 19.41% |
$155,280
$29.73 p/Share
|
Mar 07
2022 |
CRLKP
|
Kristopher H Roy
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,400 Reduced 11.28% |
$130,812
$29.73 p/Share
|
Mar 07
2022 |
CCRN
|
Susan E Ball
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 17,458 Reduced 7.82% |
$361,730
$20.72 p/Share
|
Mar 07
2022 |
CCRN
|
William J. Burns
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.91% |
$205,400
$20.54 p/Share
|
Mar 07
2022 |
DGII
|
James J. Loch
SR VP, CFO AND TREASURER |
BUY
Open market or private purchase
|
Direct | 2,500 Added 2.59% |
$49,150
$19.66 p/Share
|
Mar 07
2022 |
PRDO
|
Dennis Chookaszian |
BUY
Exercise of conversion of derivative security
|
Direct | 16,000 Added 25.6% |
$104,160
$6.51 p/Share
|
Mar 07
2022 |
WLKP
|
Andrew Kenner
SVP, Olefin Material & Corp Pr |
BUY
Open market or private purchase
|
Direct | 8,000 Added 21.05% |
$209,200
$26.15 p/Share
|
Mar 07
2022 |
HEES
|
Leslie S Magee
CFO & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 1,887 Reduced 1.82% |
$72,442
$38.39 p/Share
|
Mar 07
2022 |
HEES
|
Leslie S Magee
CFO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 3,603 Added 3.35% |
$138,319
$38.39 p/Share
|
Mar 07
2022 |
HEES
|
Bradley W Barber
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,172 Reduced 2.19% |
$121,773
$38.39 p/Share
|
Mar 07
2022 |
HEES
|
Bradley W Barber
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 6,698 Added 4.42% |
$257,136
$38.39 p/Share
|
Mar 07
2022 |
HEES
|
John Engquist
Exec. Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct | 2,857 Reduced 0.12% |
$109,680
$38.39 p/Share
|
Mar 07
2022 |
HEES
|
John Engquist
Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct | 7,744 Added 0.32% |
$297,292
$38.39 p/Share
|
Mar 07
2022 |
HEES
|
John Mc Dowell Engquist
President & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,022 Reduced 2.16% |
$39,235
$38.39 p/Share
|
Mar 07
2022 |
HEES
|
John Mc Dowell Engquist
President & COO |
BUY
Grant, award, or other acquisition
|
Direct | 1,951 Added 3.97% |
$74,899
$38.39 p/Share
|
Mar 07
2022 |
AGM
|
Robert G Sexton
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 18.78% |
$233,000
$116.5 p/Share
|
Mar 07
2022 |
ANDE
|
William E. Krueger
President and CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 3.57% |
$196,800
$49.2 p/Share
|
Mar 07
2022 |
AMWL
|
Kurt Knight
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 25,850 Reduced 1.62% |
$94,870
$3.67 p/Share
|
Mar 07
2022 |
AMWL
|
Bradford Gay
Senior VP, General Counsel |
SELL
Open market or private sale
|
Direct | 12,499 Reduced 1.39% |
$46,371
$3.71 p/Share
|
Mar 07
2022 |
CDNA
|
Peter Maag |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.11% |
$332,000
$33.2 p/Share
|
Mar 07
2022 |
CDNA
|
Peter Maag |
BUY
Exercise of conversion of derivative security
|
Direct | 4,056 Added 1.24% |
$74,225
$18.3 p/Share
|
Mar 07
2022 |
ADPT
|
Lance Baldo
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,373 Reduced 10.37% |
$28,500
$12.01 p/Share
|
Mar 07
2022 |
FBNC
|
Dexter V Perry
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 37.74% |
$41,850
$41.85 p/Share
|
Mar 07
2022 |
ZNTL
|
Cam Gallagher
President, Interim CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 2.59% |
$452,300
$45.23 p/Share
|
Mar 07
2022 |
RELY
|
Charles H Stonecipher
Director |
BUY
Other acquisition or disposition
|
Direct | 291,204 Added 50.0% |
-
|
Mar 07
2022 |
CTKB
|
Ming Yan
CHIEF TECHNOLOGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 73,011 Added 0.89% |
$43,076
$0.59 p/Share
|
Mar 07
2022 |
PLAY
|
Margo Lynn Manning
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 104 Added 0.07% |
$527
$5.07 p/Share
|
Mar 07
2022 |
APPS
|
Michelle M Sterling
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 5.36% |
$36,790
$36.79 p/Share
|
Mar 07
2022 |
NPO
|
Eric A. Vaillancourt
President and CEO |
BUY
Open market or private purchase
|
Direct | 1,000 Added 5.26% |
$97,450
$97.45 p/Share
|
Mar 07
2022 |
UTZ
|
John W Altmeyer
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 12.47% |
$68,850
$13.77 p/Share
|
Mar 07
2022 |
UTZ
|
Cary Devore
EVP, Chief Op & Transform Ofc |
BUY
Open market or private purchase
|
Direct | 7,225 Added 2.56% |
$99,922
$13.83 p/Share
|
Mar 07
2022 |